Has documented historical diagnostic right heart catheterization (RHC), with the diagnosis of pulmonary arterial hypertension (PAH), also known as Group 1 pulmonary hypertension (PH), in any of the following subtypes: Idiopathic PAH, Heritable PAH, Drug/toxin-induced PAH, PAH associated with connective tissue disease, and PAH associated with simple, congenital systemic-to-pulmonary shunts at least 1 year following repair
Has been on stable doses of PAH background therapies and diuretics (if applicable)
Has symptomatic PAH classified as World Health Organization (WHO) Functional Classification (FC) II or III
You may not be if
Has a diagnosis of Groups 2, 3, 4, or 5 PH
Has a diagnosis of the following PAH (Group 1 PH) subtypes: human immunodeficiency virus (HIV)-associated PAH, PAH associated with portal hypertension, schistosomiasis-associated PAH, PAH diagnosed with pulmonary veno occlusive disease (PVOD) or pulmonary capillary hemangiomatosis (PCH)
Has uncontrolled systemic hypertension
Has a history of full or partial pneumonectomy
Has untreated more than mild obstructive sleep apnea
Has known history of portal hypertension or chronic liver disease, including hepatitis B and/or hepatitis C
Has a history of restrictive, constrictive, or congestive cardiomyopathy
Has significant mitral regurgitation or aortic regurgitation valvular disease, mitral stenosis, and more than mild aortic valve stenosis
Has known malignancy that is progressing or has required active treatment within the past 5 years
